Pravin Ghadge
Overview
Explore the profile of Pravin Ghadge including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
15
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sahay R, Gangwani D, Singh M, Gupta S, Kale N, Srivastava M, et al.
Diabetes Obes Metab
. 2025 Feb;
27(4):2193-2205.
PMID: 39950245
Aim: To evaluate the efficacy and safety of a triple fixed-dose combination (FDC) therapy of dapagliflozin + glimepiride + metformin hydrochloride extended-release (DAPA + GLIM + MET ER) tablets in...
2.
Kapadia S, Nageswaramma S, Shah K, Singh A, Mahajan S, Deshpande A, et al.
Cureus
. 2024 Feb;
16(1):e53125.
PMID: 38420062
Background: Chronic spontaneous urticaria (CSU) is a debilitating affliction that affects diverse quality of life (QoL) parameters such as sleep, self-esteem, and daily activities. Second-generation antihistamines, such as desloratadine, are...
3.
Patel R, Ghadge P, Nair P, Kumar M, Adhikary L
Expert Opin Biol Ther
. 2022 Aug;
22(10):1293-1310.
PMID: 35968654
Introduction: There is growing interest in the development of multiple presentations for biological products for subcutaneous (SC) injection for life cycle management and product differentiation. Bridging clinical studies are required...
4.
Apsangikar P, Ghadge P, Naik M, Nair S, Payghan R
Clin Ophthalmol
. 2021 Jul;
15:3087-3095.
PMID: 34295147
Purpose: The study was undertaken for regulatory purposes to establish clinical biosimilarity and interchangeability of a ranibizumab biosimilar with reference product. Patients And Methods: A total of 159 subjects with...
5.
Apsangikar P, Ghadge P, Naik M, Nair S
J Assoc Physicians India
. 2020 Nov;
68(12):61-65.
PMID: 33247645
Purpose Of Study: Omalizumab the first anti-IgE antibody is proven with several real-world studies and meta-analyses as important adjuvant in severe allergic asthma. This study was undertaken for the first...